Iron and Cancer.
暂无分享,去创建一个
[1] S. Petrillo,et al. The Multifaceted Role of Heme in Cancer , 2020, Frontiers in Oncology.
[2] Yanhong Zhang,et al. Mdm2 is a target and mediator of IRP2 in cell growth control , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] S. Gandini,et al. Carcinogenicity of High Consumption of Meat and Lung Cancer Risk Among Non-Smokers: A Comprehensive Meta-Analysis , 2018, Nutrition and cancer.
[4] B. Stockwell,et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.
[5] T. Bai,et al. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. , 2017, Biochemical and biophysical research communications.
[6] V. Khanna,et al. Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma , 2017, Journal of cancer research and therapeutics.
[7] A. Beggs,et al. BRAF mutations are associated with increased iron regulatory protein‐2 expression in colorectal tumorigenesis , 2017, Cancer science.
[8] A. Schneeweiss,et al. Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2) , 2017, Breast Cancer Research and Treatment.
[9] Brian J. Smith,et al. O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. , 2017, Cancer cell.
[10] G. Ning,et al. Iron addiction: A novel therapeutic target in ovarian cancer , 2017, Oncogene.
[11] L. Schöckel,et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells , 2017, Cell Death and Disease.
[12] N. D. Turner,et al. Association between red meat consumption and colon cancer: A systematic review of experimental results , 2017, Experimental biology and medicine.
[13] E. Yamazaki,et al. Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphoma , 2017, International journal of laboratory hematology.
[14] Nicholas F. Marko,et al. Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas , 2016, PloS one.
[15] J. Ho,et al. Dietary Protein Sources and Incidence of Breast Cancer: A Dose-Response Meta-Analysis of Prospective Studies , 2016, Nutrients.
[16] B. Shi,et al. EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1. , 2016, Cancer letters.
[17] B. Győrffy,et al. Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis. , 2016, Cell metabolism.
[18] Q. Pan,et al. Ferroptosis is an autophagic cell death process , 2016, Cell Research.
[19] G. Ichim,et al. A fate worse than death: apoptosis as an oncogenic process , 2016, Nature Reviews Cancer.
[20] Anna Song,et al. Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer , 2016, Journal of Cancer.
[21] R. Stolzenberg-Solomon,et al. Are meat and heme iron intake associated with pancreatic cancer? Results from the NIH‐AARP diet and health cohort , 2016, International journal of cancer.
[22] O. Franco,et al. Dietary mineral intake and lung cancer risk: the Rotterdam Study , 2016, European Journal of Nutrition.
[23] M. Rauh,et al. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema , 2016, Oncotarget.
[24] Gretchen L. Gierach,et al. Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH‐AARP Diet and Health Study , 2016, International journal of cancer.
[25] T. Ganz,et al. Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics. , 2016, Biochimica et biophysica acta.
[26] F. Torti,et al. Iron and cancer: recent insights , 2016, Annals of the New York Academy of Sciences.
[27] D. Alexander,et al. A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer , 2015, Nutrition Journal.
[28] A. Tjønneland,et al. Body iron status and gastric cancer risk in the EURGAST study , 2015, International journal of cancer.
[29] W. Berger,et al. Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy , 2015, Oncotarget.
[30] Nupur K. Das,et al. Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. , 2015, Cancer cell.
[31] A. Pietrangelo. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin. , 2015, Gastroenterology.
[32] W. Willett,et al. Processed and Unprocessed Red Meat and Risk of Colorectal Cancer: Analysis by Tumor Location and Modification by Time , 2015, PloS one.
[33] Minghui Gao,et al. Glutaminolysis and Transferrin Regulate Ferroptosis. , 2015, Molecular cell.
[34] B. Stockwell,et al. Elucidating Compound Mechanism of Action by Network Perturbation Analysis , 2015, Cell.
[35] L. Miller,et al. Hepcidin regulation in prostate and its disruption in prostate cancer. , 2015, Cancer research.
[36] Nils Eling,et al. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells , 2015, Oncoscience.
[37] P. Adams,et al. Epidemiology and diagnostic testing for hemochromatosis and iron overload , 2015, International journal of laboratory hematology.
[38] Wei Wei,et al. Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies , 2015, Breast Cancer Research and Treatment.
[39] N. Naud,et al. A central role for heme iron in colon carcinogenesis associated with red meat intake. , 2015, Cancer research.
[40] Panagiotis K. Papasaikas,et al. Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis. , 2015, Molecular cell.
[41] Panagiotis K. Papasaikas,et al. Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. , 2014, Molecular cell.
[42] Daoqiang Zhang,et al. Disordered hepcidin-ferroportin signaling promotes breast cancer growth. , 2014, Cellular signalling.
[43] John A. Tallarico,et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo , 2014, Nature Cell Biology.
[44] Nishant Bhatta,et al. The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway , 2014, Oncotarget.
[45] T. Ganz,et al. Anemia of inflammation. , 2014, Hematology/oncology clinics of North America.
[46] K. Matsuo,et al. Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. , 2014, Japanese journal of clinical oncology.
[47] X. Xue,et al. Red and processed meat consumption and the risk of lung cancer: a dose-response meta-analysis of 33 published studies. , 2014, International journal of clinical and experimental medicine.
[48] M. Fleming,et al. SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1 , 2014, Oncogene.
[49] G. Waeber,et al. Physiology of Iron Metabolism , 2014, Transfusion Medicine and Hemotherapy.
[50] M. McDevitt,et al. A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms , 2014, Haematologica.
[51] M. Minden,et al. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies , 2014, American journal of hematology.
[52] Douglas B Kell,et al. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. , 2014, Metallomics : integrated biometal science.
[53] Tom C. Karagiannis,et al. Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy , 2014, The Journal of Membrane Biology.
[54] Yan Ma,et al. High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy , 2014, Science Translational Medicine.
[55] R. Kelishadi,et al. Review on iron and its importance for human health , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[56] L. Miller,et al. IRP2 regulates breast tumor growth. , 2014, Cancer research.
[57] Hong-yan Cheng,et al. Meat Consumption Is Associated with Esophageal Cancer Risk in a Meat- and Cancer-Histological-Type Dependent Manner , 2014, Digestive Diseases and Sciences.
[58] J. Gohagan,et al. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. , 2013, Journal of the National Cancer Institute.
[59] A. Agudo,et al. Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[60] Shun-Fa Yang,et al. Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cells , 2013, The Prostate.
[61] Antonina Rait,et al. Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] F. Torti,et al. Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.
[63] E. Verdin,et al. Sirtuin-3 (SIRT3) and the Hallmarks of Cancer. , 2013, Genes & cancer.
[64] D. Berg,et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial , 2013, Cancer Chemotherapy and Pharmacology.
[65] D. Greenwood,et al. Red and processed meat intake and risk of colorectal adenomas: a systematic review and meta-analysis of epidemiological studies , 2013, Cancer Causes & Control.
[66] M. Zheng,et al. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway , 2013, Molecular Pharmacology.
[67] D. Richardson,et al. The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action , 2013, Molecular Pharmacology.
[68] E. Vogtmann,et al. Meat consumption and risk of lung cancer: evidence from observational studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[69] R. Goldbohm,et al. Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[70] E. McGhee,et al. Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo. , 2012, Cell reports.
[71] Y. Kanai,et al. Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer , 2012, PloS one.
[72] F. Clavel-Chapelon,et al. Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study , 2012, International journal of cancer.
[73] D. Steensma,et al. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] C. Santos,et al. STEAP Proteins: From Structure to Applications in Cancer Therapy , 2012, Molecular Cancer Research.
[75] M. Cappellini,et al. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. , 2012, Blood reviews.
[76] J. Imlay,et al. Mononuclear Iron Enzymes Are Primary Targets of Hydrogen Peroxide Stress* , 2012, The Journal of Biological Chemistry.
[77] W. Turski,et al. Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies. , 2012, Cancer epidemiology.
[78] S. Larsson,et al. Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies , 2012, British Journal of Cancer.
[79] Suzy V. Torti,et al. An iron regulatory gene signature predicts outcome in breast cancer. , 2011, Cancer research.
[80] Dana Pe'er,et al. Modulatory profiling identifies mechanisms of small molecule-induced cell death , 2011, Proceedings of the National Academy of Sciences.
[81] S. Terai,et al. Deferoxamine for advanced hepatocellular carcinoma. , 2011, The New England journal of medicine.
[82] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[83] Yun Wu,et al. Relationships of lipocalin 2 with breast tumorigenesis and metastasis , 2011, Journal of cellular physiology.
[84] F. Pierre,et al. Heme Iron from Meat and Risk of Colorectal Cancer: A Meta-analysis and a Review of the Mechanisms Involved , 2011, Cancer Prevention Research.
[85] P. Mink,et al. A review and meta-analysis of red and processed meat consumption and breast cancer , 2010, Nutrition Research Reviews.
[86] Dominik D Alexander,et al. A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer , 2010, Nutrition journal.
[87] A. Ganser,et al. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. , 2010, Leukemia research.
[88] G. Pinkus,et al. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. , 2010, American journal of clinical pathology.
[89] M. Willingham,et al. Ferroportin and iron regulation in breast cancer progression and prognosis. , 2010, Science translational medicine.
[90] R. Strong,et al. Iron Traffics in Circulation Bound to a Siderocalin (Ngal)-Catechol Complex , 2010, Nature chemical biology.
[91] C. Ouzounis,et al. Tumorigenic Properties of Iron Regulatory Protein 2 (IRP2) Mediated by Its Specific 73-Amino Acids Insert , 2010, PloS one.
[92] D. Alexander,et al. Meta‐Analysis of Prospective Studies of Red Meat Consumption and Colorectal Cancer , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[93] L. Valenti,et al. Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload , 2010, Hepatology.
[94] J. Kolesar,et al. A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503 , 2010, Investigational New Drugs.
[95] M. Bredel,et al. Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults , 2009, BMC Cancer.
[96] C. McCarty,et al. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2009, British Journal of Cancer.
[97] R. Sinha,et al. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. , 2009, The American journal of clinical nutrition.
[98] P. Kochanek,et al. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. , 2009, Free radical biology & medicine.
[99] M. Diederich,et al. Linking anemia to inflammation and cancer: the crucial role of TNFalpha. , 2009, Biochemical pharmacology.
[100] F. Torti,et al. Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest* , 2008, Journal of Biological Chemistry.
[101] P. Kyyrönen,et al. Exposure to iron and welding fumes and the risk of lung cancer. , 2008, Scandinavian journal of work, environment & health.
[102] P. Lavori,et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. , 2008, Journal of the National Cancer Institute.
[103] P. Oates,et al. Mechanisms of heme iron absorption: current questions and controversies. , 2008, World journal of gastroenterology.
[104] B. Stockwell,et al. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. , 2008, Chemistry & biology.
[105] Rebecca C Taylor,et al. Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.
[106] B. Cooper,et al. A role for iron in Wnt signalling , 2008, Oncogene.
[107] L. Wideroff,et al. Cancer incidence in blood transfusion recipients. , 2007, Journal of the National Cancer Institute.
[108] Robin Mathew,et al. Role of autophagy in cancer , 2007, Nature Reviews Cancer.
[109] I. Orienti,et al. Sodium Ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake , 2007, Molecular Cancer.
[110] E. Eisenhauer,et al. Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161) , 2007, Investigational New Drugs.
[111] G. Berx,et al. Modulation of iron transport proteins in human colorectal carcinogenesis , 2006, Gut.
[112] Y. Aida,et al. Human immunodeficiency virus type 1 Vpr induces cell cycle arrest at the G(1) phase and apoptosis via disruption of mitochondrial function in rodent cells. , 2006, Microbes and infection.
[113] D. Ovcharenko,et al. Neutrophil gelatinase-associated lipocalin as a survival factor. , 2005, The Biochemical journal.
[114] Jiahuai Han,et al. Distinct Roles of Basal Steady-State and Induced H-Ferritin in Tumor Necrosis Factor-Induced Death in L929 Cells , 2005, Molecular and Cellular Biology.
[115] Shizuo Akira,et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.
[116] Mark H Ellisman,et al. Disruption of Mitochondrial Function during Apoptosis Is Mediated by Caspase Cleavage of the p75 Subunit of Complex I of the Electron Transport Chain , 2004, Cell.
[117] M. Brechbiel,et al. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. , 2004, Biochemical Pharmacology.
[118] J. Verrax,et al. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death , 2004, Apoptosis.
[119] J. Lambeth. NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.
[120] J. Freudenheim,et al. Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. , 2004, Annals of epidemiology.
[121] Wim Declercq,et al. Differential Signaling to Apoptotic and Necrotic Cell Death by Fas-associated Death Domain Protein FADD* , 2004, Journal of Biological Chemistry.
[122] Xi Huang. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. , 2003, Mutation research.
[123] J. Dipersio,et al. Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. , 2003, Leukemia research.
[124] R. Hultcrantz,et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.
[125] R. Kittles,et al. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. , 2003, Blood cells, molecules & diseases.
[126] R. Weissleder,et al. The transferrin receptor: a potential molecular imaging marker for human cancer. , 2003, Neoplasia.
[127] D. Richardson,et al. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1. , 2003, Carcinogenesis.
[128] Michael Hambidge,et al. Biomarkers of trace mineral intake and status. , 2003, The Journal of nutrition.
[129] E. Pietsch,et al. Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones* , 2003, The Journal of Biological Chemistry.
[130] S. Bingham,et al. Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. , 2002, The Journal of nutrition.
[131] M. Willingham,et al. Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis* , 2002, The Journal of Biological Chemistry.
[132] M. Willingham,et al. p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator. , 2001, Carcinogenesis.
[133] P. Aisen,et al. Chemistry and biology of eukaryotic iron metabolism. , 2001, The international journal of biochemistry & cell biology.
[134] C. Beaumont,et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[135] Bruno Turlin,et al. A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.
[136] Brian Seed,et al. Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.
[137] G. Andrei,et al. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. , 2000, The Journal of investigative dermatology.
[138] A. Sesink,et al. Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. , 2000, Carcinogenesis.
[139] R J Simpson,et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.
[140] A. Sesink,et al. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. , 1999, Cancer research.
[141] J. Groopman,et al. Chemotherapy-induced anemia in adults: incidence and treatment. , 1999, Journal of the National Cancer Institute.
[142] Z. Kırkalı,et al. Serum Ferritin as a Clinical Markerfor Renal Cell Carcinoma: Influenc e of Tumor Size and Volume , 1999, Urologia Internationalis.
[143] Kou-Juey Wu,et al. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. , 1999, Science.
[144] R. Sinha,et al. Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[145] M. Tso,et al. Iron-induced apoptosis in the photoreceptor cells of rats. , 1998, Investigative ophthalmology & visual science.
[146] V. Gordeuk,et al. Hepatocellular carcinoma and African iron overload. , 1995, Gut.
[147] J. Blatt. Deferoxamine in children with recurrent neuroblastoma. , 1994, Anticancer research.
[148] S. Toyokuni,et al. DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate , 1994, International journal of cancer.
[149] B. Graubard,et al. Moderate elevation of body iron level and increased risk of cancer occurrence and death , 1994, International journal of cancer.
[150] T. Saika,et al. Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. , 1993, The Journal of biological chemistry.
[151] S. Elledge,et al. Ribonucleotide reductase: regulation, regulation, regulation. , 1992, Trends in biochemical sciences.
[152] M. Stahlhut,et al. Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice , 1991, Cancer.
[153] S. White,et al. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. , 1990, Cancer research.
[154] M. Björkholm,et al. The incidence of cancer among blood donors. , 1990, International journal of epidemiology.
[155] A. Donfrancesco,et al. Effects of a single course of deferoxamine in neuroblastoma patients. , 1990, Cancer research.
[156] K. McGlynn,et al. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease , 1990, Cancer.
[157] M. Stahlhut,et al. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. , 1988, Cancer research.
[158] J. Eaton,et al. Dietary suppression of colonic cancer fiber or phytate? , 1985, Cancer.
[159] H. Sather,et al. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. , 1985, Cancer research.
[160] F. Lopez,et al. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[161] A. Kubo,et al. Serum Ferritin Levels in Patients with Cervical Cancer , 1980, Obstetrics and gynecology.
[162] L. Pauling,et al. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[163] N. Zinberg,et al. Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. , 1975, Journal of the National Cancer Institute.
[164] D. Katz,et al. Ferritin, a Hodgkin's disease associated antigen. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[165] N. Zinberg,et al. Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoadsorbents. , 1974, Archives of biochemistry and biophysics.
[166] H. Richmond. Induction of Sarcoma in the Rat by Iron—Dextran Complex , 1959, British medical journal.
[167] G. Ball,et al. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen , 2009, Breast Cancer Research and Treatment.
[168] J. J. Caro,et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. , 2001, Cancer.
[169] D. Ferrigno,et al. Serum ferritin levels in lung cancer patients. , 1992, European journal of cancer.
[170] R. Stjernholm,et al. Preliminary evaluation of platinum transferrin (MPTC-63) as a potential nontoxic treatment for breast cancer. , 1988, Cancer detection and prevention.
[171] E. Weinberg. Iron, infection, and neoplasia. , 1986, Clinical physiology and biochemistry.
[172] G. Ozolins,et al. WHO guidelines for drinking-water quality. , 1984, WHO chronicle.